Aqr Capital Management LLC Bluebird Bio, Inc. Transaction History

Aqr Capital Management LLC

  • $71.5 Billion
  • Q3 2024

A detailed history of Aqr Capital Management LLC transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 678,248 shares of BLUE stock, worth $203,474. This represents 0.0% of its overall portfolio holdings.

Number of Shares
678,248
Previous 1,334,519 49.18%
Holding current value
$203,474
Previous $1.31 Million 73.07%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$0.47 - $1.35 $308,447 - $885,965
-656,271 Reduced 49.18%
678,248 $352,000
Q2 2024

Aug 14, 2024
BUY
$0.85 - $1.26 $861,172 - $1.28 Million
1,013,144 Added 315.25%
1,334,519 $1.31 Million
Q1 2024

May 15, 2024
BUY
$0.91 - $1.75 $121,567 - $233,784
133,591 Added 71.14%
321,375 $411,000
Q4 2023

Feb 14, 2024
BUY
$1.32 - $4.83 $227,445 - $832,242
172,307 Added 1113.31%
187,784 $259,000
Q3 2023

Nov 14, 2023
SELL
$3.02 - $4.05 $187,587 - $251,565
-62,115 Reduced 80.05%
15,477 $47,000
Q2 2023

Aug 14, 2023
SELL
$2.79 - $5.03 $6,034 - $10,879
-2,163 Reduced 2.71%
77,592 $255,000
Q1 2023

May 15, 2023
BUY
$3.14 - $8.22 $127,044 - $332,581
40,460 Added 102.96%
79,755 $253,000
Q4 2022

Feb 14, 2023
SELL
$5.77 - $8.49 $96,653 - $142,215
-16,751 Reduced 29.89%
39,295 $271,000
Q3 2022

Nov 14, 2022
BUY
$3.75 - $7.39 $210,172 - $414,179
56,046 New
56,046 $349,000
Q4 2021

Feb 14, 2022
SELL
$8.96 - $16.31 $477,245 - $868,735
-53,264 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$11.24 - $21.0 $351,980 - $657,615
31,315 Added 142.67%
53,264 $992,000
Q2 2021

Aug 16, 2021
BUY
$18.04 - $22.09 $219,691 - $269,012
12,178 Added 124.63%
21,949 $665,000
Q1 2021

May 17, 2021
BUY
$16.59 - $33.89 $78,172 - $159,689
4,712 Added 93.14%
9,771 $290,000
Q4 2020

Feb 16, 2021
BUY
$27.5 - $37.92 $139,122 - $191,837
5,059 New
5,059 $218,000
Q3 2020

Nov 16, 2020
SELL
$34.44 - $43.75 $473,136 - $601,037
-13,738 Closed
0 $0
Q2 2020

Aug 17, 2020
BUY
$27.12 - $45.97 $372,574 - $631,535
13,738 New
13,738 $828,000
Q4 2018

Feb 14, 2019
SELL
$59.1 - $93.26 $700,453 - $1.11 Million
-11,852 Closed
0 $0
Q3 2018

Nov 15, 2018
SELL
$88.86 - $117.49 $2.31 Million - $3.05 Million
-25,984 Reduced 68.68%
11,852 $1.73 Million
Q2 2018

Aug 14, 2018
SELL
$99.64 - $127.59 $3.11 Million - $3.99 Million
-31,234 Reduced 45.22%
37,836 $5.94 Million
Q1 2018

May 15, 2018
BUY
$105.8 - $150.94 $808,629 - $1.15 Million
7,643 Added 12.44%
69,070 $11.8 Million
Q4 2017

Feb 14, 2018
BUY
$81.25 - $130.7 $696,393 - $1.12 Million
8,571 Added 16.22%
61,427 $10.9 Million
Q3 2017

Nov 14, 2017
BUY
$57.74 - $91.42 $3.05 Million - $4.83 Million
52,856
52,856 $7.26 Million

Others Institutions Holding BLUE

# of Institutions
151
Shares Held
63.4M
Call Options Held
264K
Put Options Held
428K
View Full List

About bluebird bio, Inc.

BLUE Quotes by TradingView
  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $23.1M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email